CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Sees Significant Drop in Short Interest

CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) saw a large decline in short interest during the month of January. As of January 30th, there was short interest totaling 74,980 shares, a decline of 25.0% from the January 15th total of 100,000 shares. Based on an average trading volume of 77,152,161 shares, the short-interest ratio is presently 0.0 days. Based on an average trading volume of 77,152,161 shares, the short-interest ratio is presently 0.0 days.

CNBX Pharmaceuticals Price Performance

OTCMKTS CNBX opened at $0.00 on Monday. CNBX Pharmaceuticals has a 12 month low of $0.00 and a 12 month high of $0.02.

About CNBX Pharmaceuticals

CNBX Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the research and development of synthetic cannabinoid-based drug candidates. The company’s proprietary platform applies medicinal chemistry techniques to design novel small-molecule analogs of naturally occurring cannabinoids, aiming to improve efficacy and safety compared with existing therapies. Its pipeline includes multiple preclinical compounds targeting neuropathic and chronic pain, with a goal of advancing these candidates through IND-enabling studies.

Headquartered in Costa Mesa, California, CNBX Pharmaceuticals collaborates with contract research organizations and academic partners to conduct pharmacology and toxicology studies as well as scale up manufacturing processes.